Neoadjuvant PD-1/PD-L1 inhibitors combined with chemotherapy in gastric cancer and gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis of single-arm studies
BackgroundNeoadjuvant chemotherapy, particularly neoadjuvant immunotherapy, has achieved significant progress in treating gastric cancer (GC) and gastroesophageal junction (GEJ) adenocarcinoma. While PD-1/PD-L1 inhibitors have improved survival outcomes in some patients, the efficacy of combining ne...
שמור ב:
| Principais autores: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Frontiers Media S.A.
2025-08-01
|
| סדרה: | Frontiers in Medicine |
| נושאים: | |
| גישה מקוונת: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1625259/full |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
